Skip to main content

Table 2 Sensitivity of aptamer-resistant RTs to NRTIs and NNRTIsAssays were performed as described in the text. Data represent mean ± SEM of three independent experiments.

From: HIV-1 reverse transcriptase mutations that confer decreased in vitro susceptibility to anti-RT DNA aptamer RT1t49 confer cross resistance to other anti-RT aptamers but not to standard RT inhibitors

 

WT

N255D

N265D

Dbl

Inhibitor

aIC50, μM

bRatio

IC50, μM

Ratio

IC50, μM

Ratio

IC50, μM

Ratio

AZTTP

1.83 ± 0.25

1

2.67 ± 0.09

1.45

1.74 ± 0.28

0.9

2.43 ± 0.26

1.3

ddATP

0.93 ± 0.18

1

1.07 ± 0.11

1.2

0.84 ± 0.04

0.9

0.91 ± 0.07

1

ddCTP

0.88 ± 0.20

1

0.69 ± 0.07

0.8

0.72 ± 0.17

0.8

0.96 ± 0.09

1.1

3TCTP

4.37 ± 0.87

1

2.51 ± 1.04

0.6

5.02 ± 1.22

1.1

2.69 ± 0.95

0.6

d4TTP

0.79 ± 0.05

1

0.83 ± 0.14

1

0.64 ± 0.12

0.8

0.91 ± 0.10

1.2

Nevirapine

0.10 ± 0.01

1

0.06 ± 0.02

0.6

0.09 ± 0.03

0.9

0.07 ± 0.01

0.7

Delavirdine

0.37 ± 0.02

1

0.64 ± 0.03

1.7

0.36 ± 0.01

1

0.31 ± 0.01

1

  1. aConcentration of inhibitor at which 50% of the activity was inhibited.
  2. bRatio of this enzyme's drug susceptibility to that of wild type.